Oxbow Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-6,075
| Closed | -$825K | – | 233 |
|
2023
Q4 | $825K | Hold |
6,075
| – | – | 0.13% | 95 |
|
2023
Q3 | $743K | Hold |
6,075
| – | – | 0.12% | 93 |
|
2023
Q2 | $771K | Buy |
6,075
+1,200
| +25% | +$152K | 0.12% | 96 |
|
2023
Q1 | $630K | Buy |
4,875
+2,000
| +70% | +$258K | 0.11% | 112 |
|
2022
Q4 | $377K | Sell |
2,875
-2,875
| -50% | -$377K | 0.07% | 152 |
|
2022
Q3 | $673K | Hold |
5,750
| – | – | 0.11% | 133 |
|
2022
Q2 | $676K | Buy |
5,750
+1,100
| +24% | +$129K | 0.1% | 134 |
|
2022
Q1 | $606K | Buy |
4,650
+1,550
| +50% | +$202K | 0.06% | 162 |
|
2021
Q4 | $473K | Buy |
+3,100
| New | +$473K | 0.05% | 193 |
|